• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (SPARKS) BD BBL¿ CHROMAGAR® MRSA II 100MM (20 EACH); SEE H.10

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (SPARKS) BD BBL¿ CHROMAGAR® MRSA II 100MM (20 EACH); SEE H.10 Back to Search Results
Catalog Number 252353
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/07/2023
Event Type  malfunction  
Event Description
It was reported that while using the bd bbl¿ chromagar® mrsa ii 100mm (20 each) that there was a performance issue.The following information was provided by the initial reporter: according to the customer's report, the colony which grew after applying the patient's sample was identified as s.Aureus, even though mrsa is supposed to grow.
 
Manufacturer Narrative
Common device name: culture media, antimicrobial susceptibility test, excluding mueller hinton there is no 510(k) for this device as it is manufactured outside the us and not sold in the us, but it is considered to be substantially similar to the legally u.S.Marketed device bd bbl¿ chromagar® mrsa ii 100mm (20 each) , catalog number 215228 with 510k # k092767.Medical device lot #: unknown, medical device expiration date: unknown, device manufacture date: unknown.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that while using the bd bbl¿ chromagar® mrsa ii 100mm (20 each) that there was a performance issue.The following information was provided by the initial reporter: according to the customer's report, the colony which grew after applying the patient's sample was identified as s.Aureus, even though mrsa is supposed to grow.
 
Manufacturer Narrative
H.6 investigation summary: bd had not received samples or photos for evaluation.Additionally, bd was unable to determine the specific lot number associated with this complaint; therefore, a review of the device history record could not be conducted.This complaint is unable to be confirmed.If additional information is made available, this complaint will be reopened to assess the level of investigation needed.Complaints received for this device and reported condition will continue to be tracked and trended.We will continue to monitor this product.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD BBL¿ CHROMAGAR® MRSA II 100MM (20 EACH)
Type of Device
SEE H.10
Manufacturer (Section D)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer (Section G)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer Contact
phillip emmert
5859 farinon drive
san antonio, TX 78249
8448235433
MDR Report Key16854149
MDR Text Key314388808
Report Number1119779-2023-00512
Device Sequence Number1
Product Code JSO
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K092767
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 05/15/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/02/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number252353
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/15/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-